| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/22/2007 | EP1819705A1 Method for preparing hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-one esters |
| 08/22/2007 | EP1819704A1 Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase |
| 08/22/2007 | EP1819703A1 Crytalline forms of a pyrazolo `3, 4-c ü pyridine factor xa inhibitor |
| 08/22/2007 | EP1819697A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 08/22/2007 | EP1819679A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 08/22/2007 | EP1819674A2 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 08/22/2007 | EP1819338A2 Tubulin binding anti cancer agents and prodrugs thereof |
| 08/22/2007 | EP1720870B1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 08/22/2007 | EP1615919B1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
| 08/22/2007 | EP1499320B1 Novel compounds |
| 08/22/2007 | EP1467970B1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
| 08/22/2007 | EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/22/2007 | CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 08/22/2007 | CN101023083A Nitrogenous fused bicyclic compound |
| 08/22/2007 | CN101023082A Fused pyrimidones useful in the treatment and the prevention of cancer |
| 08/22/2007 | CN101023072A Piperidinyl targeting compounds that selectively bind integrins |
| 08/22/2007 | CN101022728A Imidazole compounds |
| 08/22/2007 | CN101020688A 1-(3-indolyl)-1,2,3,4-tetrahydro-beta-carboline derivative and its prepn and use |
| 08/21/2007 | US7259263 Method of synthesis of azole-containing amino acids |
| 08/21/2007 | US7259261 Racemization and enantiomer separation of clopidogrel |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259171 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 08/21/2007 | US7259167 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof |
| 08/21/2007 | US7259165 especially 3-sulfonylpyrazolo[4.3b]pyridines and 3-sulfonylpyrrolo[3.2b] and [2.3b]pyridines; treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor, such as attention deficit disorder; obsessive compulsive disorder; and withdrawal from drug, alcohol or nicotine |
| 08/21/2007 | US7259164 Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity |
| 08/21/2007 | US7259159 Vitronectin receptor antagonists for treating and preventing osteoporosis, bone disorders |
| 08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| 08/16/2007 | WO2007092436A2 Compounds for treating inflammatory disorders, demyelinating disorders and cancers |
| 08/16/2007 | WO2007092213A2 Inhibitors of e1 activating enzyme |
| 08/16/2007 | WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 08/16/2007 | WO2007092000A1 Inhibitors of hcv replication |
| 08/16/2007 | WO2007091707A1 Pharmaceutical composition for preventing and/or treating bone disease, functional food, health food, pharmaceutical preparation and tooth root-periodontal tissue formation promoting agent containing the composition |
| 08/16/2007 | WO2007091152A1 Triazolopyridine compounds |
| 08/16/2007 | WO2007090888A1 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
| 08/16/2007 | WO2007090887A1 3, 9-diazabicyclo [3.3. 1]nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors |
| 08/16/2007 | WO2007090886A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/16/2007 | WO2007090751A1 Heterobicyclic amide derivatives |
| 08/16/2007 | WO2007076086A3 Tricyclic spiro compounds useful as transforming growth factor modulators |
| 08/16/2007 | WO2007074491B1 HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS |
| 08/16/2007 | WO2007072017A3 Enzyme inhibitors |
| 08/16/2007 | WO2007070826B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 08/16/2007 | WO2007067506A3 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
| 08/16/2007 | WO2007048843A3 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 08/16/2007 | WO2007007919A3 Heterocyclic janus kinase 3 inhibitors |
| 08/16/2007 | WO2006074046A3 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 08/16/2007 | US20070191613 Process for production of pyrazole-fused ring derivatives |
| 08/16/2007 | US20070191608 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement |
| 08/16/2007 | US20070191447 Novel heterocyclic compound |
| 08/16/2007 | US20070191421 Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives |
| 08/16/2007 | US20070191420 Kinase inhibitors |
| 08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
| 08/16/2007 | US20070191416 [2-(3,4,5-trimethoxy-benzoyl)-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl]-acetic acid; allergic asthma, rhinitis, allergic nephritis, conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, anaphylactic shock, urticaria, eczema, itching, Churg-Strauss syndrome, or sinusitis |
| 08/16/2007 | US20070191401 Transplant rejection, autoimmune disease, autoimmune disease |
| 08/16/2007 | US20070191395 Heterocyclic compounds having antifungal activity |
| 08/16/2007 | US20070191394 3-[2-(3-Ethyl-ureido)-7-pyridin-3-yl-imidazo[1,2-a]pyridin-5-yl]-[1,2,4]oxadiazole-5-carboxylic acid methylamide; antibiotic resistance; grampositive, gramnegative, anaerobic bacteria; otitis; sinusitis, pharyngitis/tonsilitis, bronchitis, urinary tract infections, skin infections, pneumonia, septicemia |
| 08/16/2007 | US20070191391 Urotensin II receptor antagonists |
| 08/16/2007 | US20070191388 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, antiarthritic, anticarcinogenic, antitumor, antidiabetic; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma |
| 08/16/2007 | US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin |
| 08/16/2007 | US20070191341 N-Substituted Benzene Sulfonamides |
| 08/16/2007 | US20070191337 Annellated carbamyl-aza-heterocyclic compounds, a focused library, pharmaceutical compositions, and methods of preparing the same |
| 08/16/2007 | US20070191333 Antibacterial agents |
| 08/16/2007 | US20070191293 Inhibitors of E1 activating enzymes |
| 08/16/2007 | US20070190634 Compositions useful as inhibitors of protein kinases |
| 08/16/2007 | US20070190564 Universal nucleotides for nucleic acid analysis |
| 08/16/2007 | US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds |
| 08/16/2007 | US20070190041 Novel benzothiazepine and bensothiepine compounds |
| 08/16/2007 | CA2642209A1 Triazolopyridine compounds |
| 08/16/2007 | CA2641685A1 3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
| 08/16/2007 | CA2641683A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/16/2007 | CA2641678A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/16/2007 | CA2641055A1 Heterobicyclic amide derivatives |
| 08/16/2007 | CA2639924A1 Inhibitors of e1 activating enzymes |
| 08/16/2007 | CA2637204A1 Substituted quinolones iii |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1817312A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/15/2007 | EP1817310A1 (spirocyclylamido) aminothiophene compounds as c-kit proto-oncogene inhibitors |
| 08/15/2007 | EP1817306A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 08/15/2007 | EP1817036A2 Modulators of muscarinic receptors |
| 08/15/2007 | EP1817033A1 Treatment of inflammatory bowel disease |
| 08/15/2007 | EP1677791A4 Nitrogen-containing fused heterocyclic compounds |
| 08/15/2007 | EP1543001B1 Pyrazolopyridine derivatives as tgf beta signal transduction inhibitors for the treatment of cancer |
| 08/15/2007 | EP1539759B1 Novel imidazopyridines and their use |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/15/2007 | EP1451196B1 The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 08/15/2007 | EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | CN1331864C Novel 2,5-diazabicyclo [2.2.1] heptane derivatives |
| 08/15/2007 | CN1331857C Fused-polycyclic compounds |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018791A Process for the preparation of 6,8-substituted 1,7 naphthpyridin derivatives by reacting the 8-halo-1,7 naphthpyridin-derivate with an organic boronic acid derivatives and intermediates of this proces |
| 08/15/2007 | CN101018790A 7-azaindoles and their use as PPAR agonists |
| 08/15/2007 | CN101018789A Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| 08/15/2007 | CN101018788A Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof |
| 08/15/2007 | CN101016296A Muscarinic agonists |
| 08/14/2007 | US7256293 Imidazopyridine intermediates |
| 08/14/2007 | US7256287 small molecule inhibitors of the IgE response to allergens that are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic |
| 08/14/2007 | US7256198 Pyrimidoindolones and methods for using same |
| 08/14/2007 | US7256195 Preparation of risperidone |
| 08/14/2007 | US7256189 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors |